Thursday, May 16, 2024 5/16/2024

Identifying novel targets and mechanistic role of 8,9 unsaturated sterol accumulation on enhancement of oligodendrocyte formation

Award Number: F31NS122176
ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

Group Awards By Issue Date FY or Funding FY:

View Award Abstract

Project Summary Multiple Sclerosis (MS) is a debilitating disease that is characterized by loss of oligodendrocytes in the brain. A potential therapeutic angle for MS is through the increased differentiation of oligodendrocyte progenitor cells (OPCs) into oligodendrocytes. Increasing differentiation of OPCs is a viable therapeutic option because they are a stem cell population that is found in the adult brain with the ability to differentiate, albeit typically at lower rates than needed to alleviate the symptoms of MS. Different labs have conducted high throughput screens to identify novel small molecules that lead to increased OPC differentiation. In work from our lab, we identified a unifying mechanism of the hits from these screens. Each small molecule inhibited one of three steps within the cholesterol biosynthesis pathway, which we then identified the accumulation of the 8,9 unsaturated sterols from these steps as being the mechanism of action. Our lab has evaluated the accumulation of different sterols and the cholesterol biosynthesis pathway for other novel targets. In this proposal, we plan to elucidate different targets within the cholesterol biosynthesis pathway and evaluate potential mechanisms by which these sterols enhance oligodendrocyte formation. In Aim 1, we have developed tools and small molecules to target previously overlooked enzymes within the cholesterol biosynthesis pathway, SC4MOL, NSDHL, and HSD17B7. Potential inhibition of these three enzymes would similarly lead to accumulation of 8,9-unsaturated sterols. Therefore, we hypothesize that these enzymes provide additional therapeutic targets. In Aim 2, we propose that two parallel pathways within the cholesterol biosynthesis pathway have unique effects on oligodendrocyte differentiation. In Aim 3, we have identified two potential signaling mechanisms in which 8,9-unsaturated sterols promote OPC differentiation. Transcriptomic and proteomic analyses have been done to determine different downstream signaling pathways by which these 8,9-unsaturated sterols act through to promote OPC differentiation. Two different signaling pathways have been implicated, and this proposal evaluates whether they are the mechanism. Taken together, the experiments outlined in this proposal will provide key new findings in the search and development of remyelinating therapeutics. Both new targets (Aim 1 and 2) and the mechanism of these sterols (Aim 3) will provide a more complete picture and potential therapeutic strategies to target OPCs to repopulate oligodendrocytes in the brain.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $12,959 )
2024	2024	CASE WESTERN RESERVE UNIVERSITY	10900 EUCLID AVE	CLEVELAND	OH	44106	CUYAHOGA	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	001	3	3/19/2024	NON-COMPETING CONTINUATION	-$19,691
2024	2024	CASE WESTERN RESERVE UNIVERSITY	10900 EUCLID AVE	CLEVELAND	OH	44106	CUYAHOGA	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	003	3	3/22/2024	NON-COMPETING CONTINUATION	$0
2024	2024	CASE WESTERN RESERVE UNIVERSITY	10900 EUCLID AVE	CLEVELAND	OH	44106	CUYAHOGA	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	3	11/22/2023	NON-COMPETING CONTINUATION	$32,650
2024	2023	CASE WESTERN RESERVE UNIVERSITY	10900 EUCLID AVE	CLEVELAND	OH	44106	CUYAHOGA	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	002	2	3/22/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $12,959

Issue Date FY: 2023 ( Subtotal = $40,338 )
2023	2023	CASE WESTERN RESERVE UNIVERSITY	10900 EUCLID AVE	CLEVELAND	OH	44106	CUYAHOGA	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	2	12/5/2022	NON-COMPETING CONTINUATION	$40,338
														Subtotal = $40,338

Issue Date FY: 2022 ( Subtotal = $40,338 )
2022	2022	CASE WESTERN RESERVE UNIVERSITY	10900 EUCLID AVE	CLEVELAND	OH	44106	CUYAHOGA	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	002	1	5/2/2022	NEW	$717
2022	2022	CASE WESTERN RESERVE UNIVERSITY	10900 EUCLID AVE	CLEVELAND	OH	44106	CUYAHOGA	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	1	11/17/2021	NEW	$39,622
2022	2022	CASE WESTERN RESERVE UNIVERSITY	10900 EUCLID AVE	CLEVELAND	OH	44106	CUYAHOGA	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	003	1	6/23/2022	NEW	-$1
2022	2022	CASE WESTERN RESERVE UNIVERSITY	10900 EUCLID AVE	CLEVELAND	OH	44106	CUYAHOGA	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	001	1	11/17/2021	NEW	$0
														Subtotal = $40,338

Grand Total All Awards = $93,635

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Identifying novel targets and mechanistic role of 8,9 unsaturated sterol accumulation on enhancement of oligodendrocyte formation

Award Number: F31NS122176

ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer